107 related articles for article (PubMed ID: 3501474)
21. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement.
Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T
Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197
[TBL] [Abstract][Full Text] [Related]
22. Defective IL-10 production in severe phenotypes of Crohn's disease.
Correa I; Veny M; Esteller M; Piqué JM; Yagüe J; Panés J; Salas A
J Leukoc Biol; 2009 May; 85(5):896-903. PubMed ID: 19237638
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.
Goodwin JS; Messner RP; Peake GT
J Clin Invest; 1978 Oct; 62(4):753-60. PubMed ID: 701474
[TBL] [Abstract][Full Text] [Related]
24. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
Stevens C; Lipman M; Fabry S; Moscovitch-Lopatin M; Almawi W; Keresztes S; Peppercorn MA; Strom TB
J Pharmacol Exp Ther; 1995 Jan; 272(1):399-406. PubMed ID: 7815356
[TBL] [Abstract][Full Text] [Related]
25. Effect of thymopoietin and interleukin 2 on depressed mitogenic responsiveness and colony formation of lymphocytes from patients with preleukemia.
Knox SJ; Rosenblatt LS; Anderson RW; Greenberg BR
Thymus; 1986; 8(1-2):33-44. PubMed ID: 3487854
[TBL] [Abstract][Full Text] [Related]
26. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
27. Immunological status of patients subjected to cardiac surgery: serum levels of interleukin 6 and tumor necrosis factor alpha and the ability of peripheral blood mononuclear cells to proliferate and produce these cytokines in vitro.
Właszczyk A; Adamik B; Durek G; Kübler A; Zimecki M
Arch Immunol Ther Exp (Warsz); 1996; 44(4):225-34. PubMed ID: 9017162
[TBL] [Abstract][Full Text] [Related]
28. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis.
Godot V; Harraga S; Deschaseaux M; Bresson-Hadni S; Gottstein B; Emilie D; Vuitton DA
Eur Cytokine Netw; 1997 Dec; 8(4):401-8. PubMed ID: 9459621
[TBL] [Abstract][Full Text] [Related]
29. The mechanism of action of serum immunosuppressive factor in Crohn's disease: it blocks the growth of mitogen-stimulated lymphocytes in early G1 phase through an inhibition of transferrin receptor expression.
Iwao Y; Hibi T; Watanabe M; Takaishi H; Hosoda Y; Hayashi A; Ohara M; Ogata H; Aiso S; Toda K
J Clin Lab Immunol; 1992; 38(1):15-27. PubMed ID: 1343345
[TBL] [Abstract][Full Text] [Related]
30. Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease.
Brandt E; Müller-Alouf H; Desreumaux P; Woerly G; Colombel JF; Capron M
Eur Cytokine Netw; 1998 Dec; 9(4):647-53. PubMed ID: 9889409
[TBL] [Abstract][Full Text] [Related]
31. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes.
Chouaib S; Chatenoud L; Klatzmann D; Fradelizi D
J Immunol; 1984 Apr; 132(4):1851-7. PubMed ID: 6230395
[TBL] [Abstract][Full Text] [Related]
32. Effect of the parasite enzyme, hypodermin A, on bovine lymphocyte proliferation and interleukin-2 production via the prostaglandin pathway.
Nicolas-Gaulard I; Moire N; Boulard C
Immunology; 1995 May; 85(1):160-5. PubMed ID: 7635517
[TBL] [Abstract][Full Text] [Related]
33. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
Seitz M; Zwicker M; Wider B
J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
[TBL] [Abstract][Full Text] [Related]
34. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse.
Reinisch W; Gasché C; Tillinger W; Wyatt J; Lichtenberger C; Willheim M; Dejaco C; Waldhör T; Bakos S; Vogelsang H; Gangl A; Lochs H
Am J Gastroenterol; 1999 Aug; 94(8):2156-64. PubMed ID: 10445543
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.
Yoshioka K; Kakumu S; Murakami H; Fukui K
Clin Exp Immunol; 1984 Jun; 56(3):669-76. PubMed ID: 6235072
[TBL] [Abstract][Full Text] [Related]
36. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis.
El-Mezayen RE; Matsumoto T
Clin Immunol; 2004 Apr; 111(1):61-8. PubMed ID: 15093553
[TBL] [Abstract][Full Text] [Related]
37. Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease.
Colpaert S; Vanstraelen K; Liu Z; Penninckx F; Geboes K; Rutgeerts P; Ceuppens J
Clin Immunol; 2002 Jan; 102(1):68-76. PubMed ID: 11781069
[TBL] [Abstract][Full Text] [Related]
38. [Studies on the responsiveness of alveolar T cells to proliferative stimuli and on surface antigens].
Yamaguchi E
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):224-36. PubMed ID: 8509065
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 2 and mitogen driven proliferation in human peripheral mononuclear cells: a kinetic analysis.
Ferrero E; Manfredi A; Bianchi E; Schönheit A; Sabbadini MG; Rugarli C
Haematologica; 1989; 74(4):355-8. PubMed ID: 2507408
[TBL] [Abstract][Full Text] [Related]
40. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
